Low Cholesterol and Violent Crime
Overview
Authors
Affiliations
Background: Community cohort studies and meta-analyses of randomized trials have shown a relation between low or lowered cholesterol and death by violence (homicide, suicide, accident); in primates, cholesterol reduction has been linked to increased behavioral acts of aggression (Kaplan J, Manuck S. The effects of fat and cholesterol on aggressive behaviour in monkeys. Psychosom. Med 1990;52:226-7; Kaplan J, Shively C, Fontenot D, Morgan T, Howell S, Manuck S et al. Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behaviour in monkeys. Psychosom. Med 1994;56:479-84.). In this study we test for the first time whether cholesterol level is related to commission of violent crimes against others in a large community cohort.
Methods: We merged one-time cholesterol measurements on 79,777 subjects enrolled in a health screening project in Varmland, Sweden with subsequent police records for arrests for violent crimes in men and women aged 24-70 at enrollment; and with information on covariates. We performed a nested case control comparison of cholesterol in violent criminals - defined as those with two or more crimes of violence against others - to cholesterol in nonoffenders matched on age, enrollment year, sex, education and alcohol, using variable-ratio matching, with a nonparametric sign test.
Results: One hundred individuals met criteria for criminal violence. Low cholesterol (below the median) was strongly associated with criminal violence in unadjusted analysis (Men: risk ratio 1.94, P=0.002; all subjects risk ratio 2.32, P<0.001). Age emerged as a strong confounder. Adjusting for covariates using a matching procedure, violent criminals had significantly lower cholesterol than others identical in age, sex, alcohol indices and education, using a nonparametric sign test (P=0.012 all subjects; P=0.035 men).
Conclusions: Adjusting for other factors, low cholesterol is associated with increased subsequent criminal violence.
The Cross-Talk Between the Peripheral and Brain Cholesterol Metabolisms.
Savulescu-Fiedler I, Dorobantu-Lungu L, Dragosloveanu S, Benea S, Dragosloveanu C, Caruntu A Curr Issues Mol Biol. 2025; 47(2).
PMID: 39996836 PMC: 11853762. DOI: 10.3390/cimb47020115.
Cardiovascular therapeutics: A new potential for anxiety treatment?.
Repova K, Aziriova S, Krajcirovicova K, Simko F Med Res Rev. 2022; 42(3):1202-1245.
PMID: 34993995 PMC: 9304130. DOI: 10.1002/med.21875.
Sen P, Adewusi D, Blakemore A, Kumari V Aust N Z J Psychiatry. 2021; 56(5):451-488.
PMID: 34240626 PMC: 9036157. DOI: 10.1177/00048674211025608.
Cholesterol Metabolism: A Potential Therapeutic Target in Glioblastoma.
Ahmad F, Sun Q, Patel D, Stommel J Cancers (Basel). 2019; 11(2).
PMID: 30691162 PMC: 6406281. DOI: 10.3390/cancers11020146.
Effects of Statins and Cholesterol on Patient Aggression: Is There a Connection?.
Leppien E, Mulcahy K, Demler T, Trigoboff E, Opler L Innov Clin Neurosci. 2018; 15(3-4):24-27.
PMID: 29707423 PMC: 5906086.